CLINSPECT-M: Clinical mass spectrometry center for molecular brain research in Munich

idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
idw-Abo
Science Video Project


Teilen: 
10.02.2020 12:14

CLINSPECT-M: Clinical mass spectrometry center for molecular brain research in Munich

Dr. Ulrich Marsch Corporate Communications Center
Technische Universität München

    In a joint large-scale project, Munich scientists from proteomics, computer science and medicine investigate the causes of disorders of the central nervous system, how they can be diagnosed and how treatment response can be monitored. To this end, the Federal Ministry of Education and Research (BMBF) provides funding of 6 million euros to set up a clinical mass spectrometry center in Munich (CLINSPECT-M) for an initial period of three years.

    Mass spectrometry permits the simultaneous and quantitative determination of minute quantities of thousands of biomolecules from tissues or body fluids. Such molecular profiles for proteins will now be brought into clinical use for the first time.

    New insights into the diagnosis and monitoring of disease

    Munich is one of Germany's leading centers of neuroscience. The scientists involved in the new consortium intend to demonstrate that mass spectrometric protein analysis is suitable for the detection of clinically usable biomarkers.

    The partners involved are TUM and its University Hospital ‘rechts der Isar’, the Ludwig-Maximilians-Universität München (LMU) with its University Hospital, the Helmholtz Zentrum München and the Max Planck Institute of Biochemistry. The partners will initially be funded with approximately 6 million euros over the next three years.

    "As a core element of ‘TUM Agenda 2030’ – our strategic vision for the future –, this powerful cooperation in the clinical neurosciences constitutes a significant advance in systematically uniting Munich researchers as part of our ONE MUNICH strategy," says Prof. Thomas F. Hofmann, President of TUM.

    The members of the consortium ‘Clinical Mass Spectrometry Center Munich (CLINSPECT-M)’ see an extremely high demand for biomarkers for diagnosis, therapy decisions and monitoring of therapy response.

    Everything revolves around the brain

    The Clinspect-M network covers four major areas of application in medicine:

    ◾Multiple sclerosis: protein profiles of the cerebrospinal fluid of 4,000 patients should help physicians to find disease-specific fingerprints that can be used in clinical diagnosis.

    ◾Alzheimer's disease: clinical studies involving hundreds of patients will be used to find biomarkers that indicate whether a drug is effective or not.

    ◾Stroke: the examination of thousands of patient samples will identify proteins that indicate brain damage caused by a stroke and distinguish stroke from other causes.

    ◾Brain tumors: hundreds of cancer patients are examined with the aim of finding molecular targets for personalized therapy decisions.

    "By using bioinformatics to bring together medical information and data from mass spectrometry, we will gain a better understanding of the complex interrelationships between these diseases and translate this understanding into medical practice," explains co-spokesperson Prof. Daniel Teupser, Director of the Institute of Laboratory Medicine at LMU.

    More information:

    With its initiative "Research Nodes for Mass Spectrometry in Systems Medicine", the BMBF (Federal Ministry of Education and Research) supports the implementation of the latest technologies in medical practice. In a highly competitive procedure, four consortia from Munich, Berlin, Heidelberg and Mainz were selected from around 30 applicants.

    In addition to BMBF funding, the project also receives financial support from the Free State of Bavaria, TUM and LMU.


    Wissenschaftliche Ansprechpartner:

    Prof. Dr. Bernhard Küster
    Technical University of Munich
    Chair of Proteomics and Bioanalytics
    phone: +49-8161-7-5696
    kuster(at)tum.de


    Weitere Informationen:

    https://mediatum.ub.tum.de/1537625 (high resolution images)
    https://www.synergy-munich.de/index.html (The Excellence Cluster Synergy is also a cooperative venture between TUM and LMU.)


    Anhang
    attachment icon Entrance to the mass spectrometer

    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler, jedermann
    Biologie, Chemie, Medizin
    überregional
    Forschungsprojekte, Kooperationen
    Englisch


    Entrance to the mass spectrometer


    Zum Download

    x

    Quadrupole: Part of the ion optics of a mass spectrometer.


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).

    Cookies optimieren die Bereitstellung unserer Dienste. Durch das Weitersurfen auf idw-online.de erklären Sie sich mit der Verwendung von Cookies einverstanden. Datenschutzerklärung
    Okay